The First Thousand Days After almost 25 years of research, Dr. Tessa Roseboom, Professor of Early Development and Health has identified the first 1000 days as the most critical to shaping who we grow up to be.
Improving detection of recurrences during follow-up care in lung cancer patients Researchers from Amsterdam UMC and Radboud university medical center received a 2.5 million euro grant for promising care from the National Health Care Institute and ZonMW. They will investigate if the use of PET/CT scans during follow-up of lung cancer patients results in a higher and earlier detection rate of recurrences.
No camel feces for diarrhea A story about the history of fecal transplantation that is often cited in the scientific and popular literature states that German soldiers in the Second World War treated dysentery with camel feces. A team of microbiologists from Amsterdam UMC and the University of Amsterdam encountered this story in their research on gut health and investigated if there is any truth behind it. Their findings were published in PLOS ONE.
'Data of ICU patients can answer thousands of questions' ICUdata is an ambitious data-sharing project. Intensivist Paul Elbers, one of the initiators, is enthusiastic about the project that is entering its next phase – and it’s going far beyond its initial scope.
Prescribing of medication did not always go smoothly during corona pandemic The first patients to visit Amsterdam UMC's "post-covid-19 outpatient clinic" in 2020 taught doctors and pharmacists an important lesson: in times of a crisis, information about medication can easily be jeopardized. "This is a valuable lesson for the crises that are doubtless still to come."
New drug to treat rare swelling disorder Patients with hereditary angioedema often experience sudden swelling in their body that can be extremely painful, disabling and sometimes even fatal. A new drug can prevent these attacks and greatly improve their quality of life, according to an international study coordinated by Amsterdam UMC.
Ambitious plans to tackle urgent societal issues Predicting, delaying and curing hereditary brain diseases; development of drugs against atrial fibrillation without the use of animal testing and the neurobiological assessment of young delinquents: these ambitious plans of three consortia led by Amsterdam UMC have been awarded a total of 11.2 million euros by the Dutch Research Council NWO.
Pioneers in printing with living tissue Amsterdam UMC is a global pioneer in the area of 3D printing with living tissue. This means our researchers have to invent almost everything themselves.
Opening the blood-brain barrier with ultrasound For the first time in Europe, researchers are trying to temporarily open the blood-brain barrier in a non-invasively manner. They do this using an innovative technique applying low-focused ultrasound (FUS). This will allow drugs to reach the brain more easily.
